TMD Collaborative for IMproving PAtient-Centered Translational Research (TMD IMPACT) (U54 Clinical Trial Optional)
ID: 356761Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/356761

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-DE-25-003.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Temporomandibular Disorder (TMD) Collaborative for Improving Patient-Centered Translational Research (TMD IMPACT)," aimed at establishing a national interdisciplinary research consortium to advance research and improve clinical care for Temporomandibular Disorders (TMDs). The initiative seeks to support rigorous basic and clinical research, enhance population health research, and train a diverse biomedical workforce through the establishment of TMD IMPACT Centers, which will include various cores and research projects. With an anticipated funding availability of $7 million annually for up to two awards, applications are due by January 11, 2025. Interested applicants can find more information and submission guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-DE-25-003-Full-Announcement.html
    RFA-DE-25-003.html
    The Department of Health and Human Services, through the NIH, announces a funding opportunity titled "Temporomandibular Disorder (TMD) Collaborative for Improving Patient-Centered Translational Research (TMD IMPACT)". This initiative aims to establish a national, interdisciplinary research collaborative focused on advancing TMD research and improving clinical care. Key objectives include supporting rigorous basic research, enhancing clinical research to improve diagnosis and treatment, strengthening population health research on the burden of TMDs, and training a diverse future biomedical workforce. The research will be organized through TMD IMPACT Centers, each comprising an Administrative Core, a Bioinformatics/Data Science Core, an Outreach, Training, and Education Core, alongside one to three research projects. Each center is expected to contribute to the understanding of TMDs through comprehensive, interdisciplinary research efforts. The anticipated funding availability is $7 million annually for up to two awards, with applications due by January 11, 2025. The initiative encourages collaboration with patient advocacy groups and robust community engagement. Applications must adhere to strict submission guidelines outlined in the notification, emphasizing the importance of timely submissions and thorough compliance with application instructions.
    Similar Opportunities
    Notice of Intent to Publish a Funding Opportunity Announcement for TMD Collaborative for IMproving PAtient-Centered Translational Research (TMD IMPACT) (U54 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the TMD Collaborative for Improving Patient-Centered Translational Research (TMD IMPACT), aimed at advancing research on Temporomandibular Disorders (TMD). This initiative seeks to establish a national, interdisciplinary collaborative that will enhance TMD research, improve clinical care, and train future researchers in the field. The funding opportunity will provide a total of $7 million, with an award ceiling of $3.5 million for up to two cooperative agreements, and is expected to be published in Summer 2024, with applications due in Winter 2024. Interested applicants should prepare for the anticipated collaboration and project development in advance of the expected award date of July 1, 2025.
    Continuation or Revision of NIDCR Clinical Trial Implementation Cooperative Agreement (UH3 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Dental and Craniofacial Research (NIDCR), is offering a funding opportunity for the continuation or revision of ongoing clinical trials via a Cooperative Agreement (UH3) mechanism. This initiative aims to support clinical trials that require additional time for completion or modifications to their scope, particularly focusing on innovative treatments for dental, oral, or craniofacial diseases. Eligible applicants include a diverse range of institutions, with no budget limits specified, and the total funding available will depend on NIH appropriations and the quality of applications submitted. Interested parties should note that the application deadline is January 8, 2025, and are encouraged to contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the NIDCR Drug, Biologic, Device, and Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement, designated as UG3/UH3. This initiative aims to support the planning and execution of clinical trials that enhance dental, oral, and craniofacial health, utilizing a two-phased approach: a one-year UG3 planning phase followed by a potential five-year UH3 implementation phase. Eligible applicants include higher education institutions, nonprofits, and local or state governments, with a focus on proposals that test FDA-regulated products and involve significant NIH engagement. Interested parties should note that the application deadline is January 6, 2028, and can find further details and contact information at grantsinfo@nih.gov or through the provided link to the full opportunity announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-057.html.
    NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)" aimed at supporting the planning and implementation of clinical trials focused on behavioral and social interventions related to dental, oral, and craniofacial health. This initiative consists of a two-phase approach: the UG3 phase, which allows for up to two years of planning, and the UH3 phase, which can extend up to five years for clinical trial execution, contingent upon meeting specific scientific milestones. This grant is crucial for advancing research methodologies in dental and oral health, particularly in addressing health disparities, and is open to a diverse range of applicants, including higher education institutions and community organizations. Interested parties should note that the application deadline is January 6, 2028, with an award ceiling of $500,000, and can direct inquiries to grantsinfo@nih.gov for further information.
    NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the National Institute of Dental and Craniofacial Research (NIDCR) for investigator-initiated observational studies or biomarker validation studies that require prospective data collection. This cooperative agreement aims to support research that enhances oral health by generating robust clinical data and validating biomarkers with established preliminary data. The funding is available for projects up to five years, contingent upon NIH appropriations, and emphasizes the significance of the proposed research and the investigator's capability. Interested applicants can find more information and application guidelines at the provided link, with the application due date set for May 7, 2026, and inquiries directed to grantsinfo@nih.gov.
    Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the continuation or revision of clinical trials under the National Institute of Dental and Craniofacial Research (NIDCR) through a UH3 Exploratory/Developmental Cooperative Agreement. This initiative aims to support competing renewals or competitive revisions of ongoing clinical trials that focus on dental, oral, and craniofacial health, emphasizing the importance of structured data generation in advancing healthcare research. Eligible applicants include a wide range of institutions, such as public and private entities, nonprofits, and government organizations, with the application deadline set for January 6, 2028. Interested parties can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries regarding the application process.
    NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering Small Research Grants through the National Institute of Dental and Craniofacial Research (NIDCR) to support secondary data analyses of existing dental, oral, or craniofacial health databases, as well as the development of statistical methodologies for analyzing this data. The funding opportunity, identified as PAR-25-045, aims to enhance understanding of causality within identified risk factors and health outcomes, emphasizing innovative research that aligns with NIDCR's strategic priorities. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and governmental entities, with funding available up to $100,000 per year, totaling a maximum of $200,000 over two years. Applications will be accepted starting January 16, 2025, with submission deadlines in February and March of the same year. For more information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-045.html.
    NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Funding Opportunity Announcement (FOA) for the NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3), aimed at supporting research applications focused on planning and executing clinical trials related to dental, oral, and craniofacial health. This funding opportunity is structured in two phases: an initial one-year planning phase (UG3) followed by a potential five-year implementation phase (UH3), contingent upon meeting specific scientific milestones and feasibility requirements. The initiative seeks to expedite the development of evidence-based approaches to improve health outcomes in dentistry, emphasizing rigorous adherence to ethical and regulatory standards throughout the trial process. Interested applicants, including various higher education institutions and nonprofit organizations, must submit their applications by January 8, 2025, and can find additional information at the NIH grants website or contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for assistance.
    NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3), aimed at supporting research in behavioral and social interventions related to dental, oral, and craniofacial health. This funding opportunity encourages the development of clinical trials through a phased approach, beginning with a planning phase (UG3) lasting up to two years, which may transition into a clinical trial implementation phase (UH3) of up to five years, contingent upon meeting specific scientific milestones. The program emphasizes rigorous intervention studies that engage various stakeholders and adhere to the NIH Stage Model of intervention development, with applications due by 5:00 PM local time on January 7, 2025. For further inquiries, applicants can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov, and additional details can be found at the provided link to the full announcement.
    Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Collaborative Program Grant for Multidisciplinary Teams (RM1), aimed at funding integrated research teams of three to six Program Directors/Principal Investigators (PDs/PIs) to tackle complex biomedical questions. This initiative emphasizes the need for collaborative efforts that demonstrate synergy and diversity, with the goal of achieving significant scientific advancements within the mission of the National Institute of General Medical Sciences (NIGMS). Funding is available for new, renewal, and resubmission applications, with anticipated budgets ranging from $700,000 to $1.5 million per year, and applications must be submitted by January 27, 2026. Interested applicants can find more information and guidelines at the NIH Grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.